Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2021 Aug 24;45(11):2199–2200. doi: 10.1002/cbin.11686

Serological tests for COVID‐19: Potential opportunities

Marcarious M Tantuoyir 1,2,3, Nima Rezaei 1,4,5,
PMCID: PMC8426956  PMID: 34374484

In response to the commentary article about our recent publication in Cell Biology International (https://doi.org/10.1002/cbin.11516), which states that Hemagglutinin‐esterase protein is absent in SARS‐Cov2 as reported in Table 2 of our publication, we acknowledge the error and seek for correction. This is largely due to the uncertainties and discoveries about the SARS‐COV‐2 virus. However, the information provided in our publication was validated by Ravi et al. (2020) but upon critical consideration and extensive reviews of the viral structural proteins, the Hemagglutinin‐esterase protein is absent in the SARS‐COV‐2 viral structure (Astuti & Ysrafil, 2020; Yin, 2020). Therefore, the following correction should be made accordingly:

Table 2.

A summary of SARS‐CoV‐2 structural proteins, binding sites, and their roles (Astuti & Ysrafil, 2020)

Protein Name Binding mechanism Role
Spike protein (S) Utilizes an N‐terminal signal sequence to gain access to the ER (endoplasmic reticulum) Mediates attachment to host receptors
Nucleocapsid protein (N) Binds the viral genome in a beads‐on‐a‐string type conformation Tethers the viral genome to replicase‐transcriptase complex, packages the encapsulated genome into viral particles
Envelope protein (E) A transmembrane protein with ion channel activity Facilitates assembly and release of the virus; involved in ion channel activity
Membrane protein (M) Binds to nucleocapsid Promotes membrane curvature

Tantuoyir, M. M. , & Rezaei, N. (2021). Serological tests for COVID‐19: Potential opportunities. Cell Biol Int, 45, 2199–2200. 10.1002/cbin.11686

The article that is the subject of this Commentary is available here: https://doi.org/10.1002/cbin.11516

DATA AVAILABILITY STATEMENT

Data sharing does not apply to this article as no new data were created or analyzed in this study.

REFERENCES

  1. Astuti, I. , & Ysrafil (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2): An overview of viral structure and host response. Diabetes & Metabolic Syndrome, 14(4), 407–412. 10.1016/j.dsx.2020.04.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ravi, N. , Cortade, D. L. , Ng, E. , & Wang, S. X. (2020). Diagnostics for SARS‐CoV‐2 detection: A comprehensive review of the FDA‐EUA COVID‐19 testing landscape. Biosensors and Bioelectronics, 165, 112454. 10.1016/j.bios.2020.112454 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Yin, C. (2020). Genotyping coronavirus SARS‐CoV‐2: Methods and implications. Genomics, 112(5), 3588–3596. 10.1016/j.ygeno.2020.04.016 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing does not apply to this article as no new data were created or analyzed in this study.


Articles from Cell Biology International are provided here courtesy of Wiley

RESOURCES